You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Hypertension

Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]

  • In development
  • Reference number: GID-TA11572
  • Expected publication date:  21 May 2026
  • Project information
  • Project documents
  • Consultation

On this page

  1. Draft guidance
  2. Invitation to participate
  3. Notes
  4. Referral
  5. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6459
  6. Topic selection

Documents

Documents created during the development process.

Draft guidance

  • Draft guidance

  • Draft guidance (online commenting)

  • Draft guidance (downloadable version) (PDF 324 KB)

    Published:
    23 January 2026
  • Committee papers (PDF 13.2 MB)

    Published:
    23 January 2026
  • Public committee slides (PDF 1.12 MB)

    Published:
    23 January 2026
  • Equality impact assessment (downloadable version) (PDF 156 KB)

    Published:
    23 January 2026

Invitation to participate

  • Final scope (PDF 118 KB)

    Published:
    10 March 2025
  • Provisional stakeholder list (post-referral) (PDF 134 KB)

    Published:
    10 March 2025
  • Draft scope and provisional stakeholder list comments table (post-referral) (PDF 292 KB)

    Published:
    10 March 2025
  • Equality impact assessment (downloadable version) (PDF 107 KB)

    Published:
    10 March 2025

Notes

  • Note

Referral

  • Referral

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6459

  • Draft matrix post referral (PDF 197 KB)

    Published:
    04 November 2024
  • Draft scope post referral (PDF 191 KB)

    Published:
    04 November 2024

Topic selection

  • Topic selection

Back to top